Me Today Limited/Announcement
Me Today Limited logo

Me Today results for the 12 Month Period Ended 30 June 2023

Full Year Results29 August 2023MEEConsumer Staples

Audited results announcement for the 12 months ended 30 June 2023

Results for announcement to the market

Name of issuer Me Today Limited

Reporting Period 12 months to 30 June 2023

Previous Reporting Period 15 months to 30 June 2022

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$7,883 (4.7)%

Total Revenue $7,883 (4.7)%

Net profit/(loss) from

continuing operations

$(12,974) 33.6%

Total net profit/(loss) $(12,974) 33.6%

Interim/Final Dividend

Amount per Quoted Equity

Security

The Company does not propose to pay a dividend at this time

Imputed amount per Quoted

Equity Security

Not applicable

Record Date Not applicable

Dividend Payment Date Not applicable

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

$0.0051 $0.0114

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Refer to the audited financial statements and press release

that accompany this announcement.

Authority for this announcement

Name of person


authorised

to make this announcement

Stephen Sinclair

Contact person for this

announcement

Stephen Sinclair

Contact phone number 021 330 053

Contact email address stephen@metoday.com

Date of release through MAP


29 August 2023


Audited financial statements accompany this announcement.

---

Me Today Limited


Consolidated Financial Statements



For the year ended 30 June 2023






Me Today Limited
Consolidated Financial Statements

For the year ended 30 June 2023



Contents



Page

Consolidated Statement of Profit and Loss and Other Comprehensive Income 2

Consolidated Statement of Changes in Equity 3

Consolidated Statement of Financial Position 4

Consolidated Statement of Cash Flows 5

Notes to the Consolidated Financial Statements 6

Independent Auditor’s Report 35


Me Today Limited
Consolidated Statement of Profit and Loss and Other Comprehensive

Income

For the year ended 30 June 2023


The accompanying notes form part of these consolidated financial statements and should be read in conjunction with them.

2


30 Jun 2023 30 Jun 2022

Note(12 months)(15 months)

NZ$000NZ$000

Revenue before marketing services provided by a customer9,2018,811

Less marketing services provided by customers(1,318)(538)

Revenue57,8838,273

Changes in inventories of finished goods and work in progress(4,767)(5,132)

Selling and marketing expenses(2,968)(3,729)

Distribution expenses(861)(610)

Administrative and other operating expenses(4,881)(5,489)

Amortisation of customer relationship asset19(1,083)(1,084)

Finance income413

Finance expenses6(594)(641)

Acquisition related costs(115)(368)

Operating loss before tax, fair value adjustments,

restructuring and impairment costs6(7,382)(8,767)

Fair value loss on harvested honey14(2,223)(1,724)

Fair value loss on biological assets15(544)(720)

Restructuring costs(337)(494)

Write down of assets held for sale13(128)(543)

Impairment of goodwill19.1-(9,120)

Impairment of customer relationship asset19.1(2,360)(780)

Loss before income tax(12,974)(22,148)

Income tax (expense)/benefit8-2,604

Loss for the period attributable to owners of the company(12,974)(19,544)

Other comprehensive income

Items that may be reclassified subsequently to profit or loss

Exchange differences on translation of foreign operations(69)-

Total comprehensive loss for the period attributable to

owners of the company

(13,043)(19,544)

Earnings (loss) per share:

Basic and diluted loss per share (NZ$)9(0.009)(0.029)

Me Today Limited
Consolidated Statement of Changes in Equity

For the year ended 30 June 2023


The accompanying notes form part of these consolidated financial statements and should be read in conjunction with them.

3



Share

Share based

paymentsAccumulated

Foreign

currency

translationTotal

Notecapitalreservelossesreserveequity

NZ$000NZ$000NZ$000NZ$000

At 1 April 202113,669110(7,887)-5,892

Total comprehensive income

Loss attributable to owners of the company--(19,544)-(19,544)

Transactions with owners

Shares issued during the period2228,733(177)--28,556

Less: share issue costs(975)---(975)

Shares issued on acquisition of subsidiaries10,000---10,000

Share options issued24-30--30

Share options expired23-(26)26--

Other share based payments23-140--140

At 30 June 202251,42777(27,405)-24,099

Total comprehensive income

Loss attributable to owners of the company--(12,974)-(12,974)

Exchange differences on translation foreign operations---(69)(69)

Transactions with owners

Shares issued during the period221,026(159)--867

Less: share issue costs(72)---(72)

Share options issued23-----

Share options expired23-(13)--(13)

Other share based payments23-95--95

At 30 June 202352,381-(40,379)(69)11,933

Me Today Limited
Consolidated Statement of Financial Position

As at 30 June 2023


The accompanying notes form part of these consolidated financial statements and should be read in conjunction with them.

4


These financial statements were approved by the Board on 29 August 2023.

Signed on behalf of the Board by:





Grant Baker Michael Kerr

Note

2023

2022

NZ$000

NZ$000

ASSETS

Current assets

Cash and cash equivalents

10

913

5,370

Trade and other receivables

11

2,443

1,199

Inventory

12

14,759

16,793

Biological work in progress

14

160

698

Taxation receivable

11

35

18,286

24,095

Assets classified as held for sale

13

93

1,063

Total current assets

18,379

25,158

Non-current assets

Biological assets

15

752

1,598

Property, plant and equipment

16

2,958

3,788

Right-of-use asset

17.1

770

1,387

Customer relationship asset

19

3,993

7,436

Intangible assets

19

98

89

Total non-current assets

8,571

14,298

Total assets

26,950

39,456

LIABILITIES

Current liabilities

Trade and other payables

20

1,777

1,766

Lease liabilities

17.2

334

316

Borrowings

21

7,248

942

Total current liabilities

9,359

3,024

Non-current liabilities

Lease liabilities

17.2

472

1,041

Borrowings

21

5,186

11,292

Total non-current liabilities

5,658

12,333

Total liabilities

15,017

15,357

Net assets

11,933

24,099

EQUITY

Share capital

22

52,381

51,427

Share based payments reserve

23

-

77

Accumulated losses

(40,379)

(27,405)

Foreign currency translation reserve

(69)

-

Total equity

11,933

24,099

Me Today Limited
Consolidated Statement of Cash Flows

For the year ended 30 June 2023


The accompanying notes form part of these consolidated financial statements and should be read in conjunction with them.

5



30 Jun 2023 30 Jun 2022

Note(12 months)(15 months)

NZ$000NZ$000

Cash flows from operating activities

Receipts from customers7,9498,270

Payments to suppliers and employees

(13,534)(19,998)

Interest received413

Income tax paid26(11)

Net cash used in operating activities25(5,555)(11,726)

Cash flows from investing activities

Proceeds from short term deposits-3,804

Acquisition of subsidiaries-(20,791)

Acquisition related costs(115)(368)

Payments for property, plant and equipment

(35)(327)

Proceeds from sale of property, plant and equipment

1,41097

Payments for intangibles

(11)126

Net cash used in investing activities1,249(17,459)

Cash flows from financing activities

Proceeds from issue of share capital

73927,983

Share capital issue costs

(72)(474)

Proceeds from bank borrowings26

-8,500

Repayment of principal on borrowings26

-(1,466)

Interest paid on borrowings26

(377)(379)

Payment of lease liabilities26

(355)(742)

Interest paid on lease liabilities26

(17)(62)

Net cash flows from financing activities(82)33,360

Net (decrease)/increase in cash and cash equivalents(4,388)4,175

Cash and cash equivalents at the beginning of the period5,3701,195

Effect of foreign exchange rates(69)-

Cash and cash equivalents at the end of the period

109135,370

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




6

1. General information

Me Today Limited (‘the Company’) is a limited liability company incorporated and domiciled in New

Zealand.

These financial statements are for Me Today Limited and its subsidiaries (together ‘the Group’). Details of

subsidiary companies and their principal activities are set out in note 27.

The Group:

• produces, sells, and markets health and wellbeing products or acts as an agent on behalf of other

health and wellbeing suppliers; and

• produces premium manuka honey.

In 2022 the Company changed its annual reporting date to 30 June and, as a result of the change, the

comparative amounts are for the 15 months ended 30 June 2022, unless otherwise stated.

2. Basis of preparation

2.1. Basis of measurement

The consolidated financial statements have been prepared on a historical cost basis, except for biological

assets which are measured at fair value less cost to sell. Historical cost is generally based on the fair

value of the consideration given in exchange for goods and services.

The consolidated financial statements are presented in New Zealand dollars which is the Company’s

functional and Group’s presentation currency, rounded to the nearest thousand dollars unless otherwise

stated.

2.2. Statement of compliance and reporting framework

The consolidated financial statements have been prepared in accordance with Generally Accepted

Accounting Practice in New Zealand (‘NZ GAAP’). The Group is a for-profit entity for the purposes of

complying with NZ GAAP. The consolidated financial statements comply with New Zealand equivalents to

International Financial Reporting Standards (‘NZ IFRS’) and International Financial Reporting Standards

(‘IFRS’).

The Company is an FMC reporting entity under the Financial Markets Conduct Act 2013. These

consolidated financial statements have been prepared in accordance with the requirements of the

Financial Markets Conduct Act 2013 and the NZX Main Board Listing Rules.

3. Significant accounting policies

The principal accounting policies adopted are set out below. There have been no changes in accounting

policies since the previous reporting date unless otherwise stated.

3.1. Principles of consolidation

The consolidated financial statements incorporate the financial statements of the Company and entities

controlled by the Company. Control is achieved when the Company:

• has power over the investee;

• is exposed, or has rights, to variable returns from its involvement with the investee; and

• has the ability to use its power to affect its returns.

The Company reassesses whether or not it controls an investee if facts and circumstances indicate that

there are changes to one or more of the three elements of control listed above.

When necessary, adjustments are made to the financial statements of subsidiaries to bring their

accounting policies into line with the Group's accounting policies.

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




7

All intragroup assets and liabilities, equity, income, expenses and cash flows relating to transactions

between members of the Group are eliminated in full on consolidation.

3.2. Revenue recognition

The Group recognises revenue from the following major sources:

• sale of goods; and

• agency services.

Revenue is measured based on the consideration to which the Group expects to be entitled in a contract

with a customer and excludes amounts collected on behalf of third parties, such as goods and service tax

and customs duties.

3.2.1. Sale of goods

The Group sells goods such as health and wellbeing products, and honey products. The Group considers

the performance obligation is satisfied when control of the goods has transferred, being when the goods

have been delivered to the customer. Revenue derived from the sale of goods is recognised at the point in

time the performance obligation is satisfied. Marketing payments paid to a customer for the purchase of

health and wellbeing products, are treated as a reduction in revenue.

3.2.2. Agency services

For revenues derived from agency services, where the Group acts as a sales agent for other health and

wellness brands, the Group considers its performance obligations are satisfied over time, on the basis that

agency services are provided and consumed by the customer on a simultaneous basis, and so will

recognise the related revenue as the performance obligation is satisfied. Revenue is measured on an

output method basis.

3.3. Income Tax

Income tax expense comprises both current and deferred tax.

3.3.1. Current tax

The tax currently payable is based on taxable profit for the period. Taxable profit differs from ‘profit before

tax’ as reported in the statement of profit or loss and other comprehensive income because of items of

income or expense that are taxable or deductible in other periods and items that are never taxable or

deductible. The Group's current tax is calculated using tax rates that have been enacted or substantively

enacted by the end of the reporting period.

3.3.2. Deferred tax

Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities

in the financial statements and the corresponding tax bases used in the computation of taxable profit.

Deferred tax liabilities are generally recognised for all taxable temporary differences except for the initial

recognition of goodwill and the initial recognition of an asset or liability in a transaction which is not a

business combination and at the time of the transaction affects neither accounting or taxable profit.

Deferred tax assets are recognised for all deductible temporary differences to the extent that it is probable

that taxable profits will be available against which those deductible temporary differences can be utilised.

Such deferred tax assets and liabilities are not recognised if the temporary difference arises from the initial

recognition (other than in a business combination) of assets and liabilities in a transaction that affects

neither the taxable profit nor the accounting profit.

Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in

which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted

or substantively enacted by the end of the reporting period.

The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow

from the manner in which the Group expects, at the end of the reporting period, to recover or settle the

carrying amount of its assets and liabilities.

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




8

3.4. Goods and services tax

Revenue, expenses, assets and liabilities are recognised net of the amount of goods and services tax

(GST) except:

• where the amount of GST incurred is not recovered from the taxation authority, it is recognised as

part of the cost of acquisition of an asset or as part of an item of expense; or

• for receivables and payables, which are recognised inclusive of GST.

The net amount of GST recoverable or payable to the taxation authority is included as part of receivables

or payables.

3.5. Inventories

Inventories are stated at the lower of cost and net realisable value. Costs of inventories are determined on

a first-in-first-out basis. Net realisable value represents the estimated selling price for inventories less

estimated costs of completion and costs necessary to make the sale.

The deemed cost for the Group’s agricultural produce (honey) inventory is fair value at harvest less

estimated point-of-sale costs. Fair value is determined by reference to selling prices for honey. Point-of-

sale costs include all costs that would be necessary to sell the assets.

3.6. Biological assets

Biological assets consist of bees (including queens).

Biological assets are measured at fair value less point-of-sale costs, with any change therein recognised

in the profit or loss. Point-of-sale costs include all costs that would be necessary to sell the assets. The fair

value of biological assets is assessed on an annual basis post-harvest, which involves reviewing the

number of operational hives in use and referencing market prices for hives.

3.7. Biological work in progress

Biological work in progress consists of unharvested honey.

Biological assets are measured at fair value less point-of-sale costs, with any change therein recognised

in the profit or loss. Point-of-sale costs include all costs that would be necessary to sell the assets.

The growth in the biological work in progress in the period from harvest to 30 June cannot be reliably

measured at fair value due to the variables in hive growth and honey production between harvest and

reporting date. Therefore, as required under NZ IAS 41: Agriculture, the cost of agricultural activity

(beekeeping costs) in the period to 30 June has been capitalised as biological work in progress to account

for this growth.

Agricultural produce (honey) from biological assets is transferred to inventory at fair value, by reference to

market prices for honey less estimated point-of-sale costs, at the date of harvest. The biological work in

progress is transferred to inventory as part of this fair value recognition at each harvest, which occurs at

least annually. A fair value loss on honey harvest was recognised in the loss for the period (note 15).

3.8. Leasing

The Group assess whether a contract is or contains a lease, at inception of the contract. The Group

recognises a right-of-use asset and a corresponding lease liability with respect to all lease arrangements

in which it is the lessee, except for short-term leases (defined as leases with a lease term of 12 months or

less) and lease of low value assets. For these leases, the Group recognises the lease payments as an

operating expense on a straight-line basis over the term of the lease unless another systematic basis is

more representative of the time pattern in which economic benefit from the leased assets are consumed.

The lease liability is initially measured at the present value of the future lease payments, discounted by

using the rate implicit in the lease. If this rate cannot be readily determined, the Group uses its incremental

borrowing rate. The lease liability is measured at amortised cost using the using the effective interest

method. It is remeasured when there is a change in future lease payments arising from a change in an

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




9

index or rate or if the Group changes its assessment of whether it will exercise a purchase, extension of

termination option, with a corresponding adjustment made to the carrying value of the right-of-use asset.

The right-of-use assets comprise the initial measurement of the corresponding lease liability, lease

payments made at or before the commencement date and any initial direct costs. They are subsequently

measured at cost less accumulated depreciation and impairment losses. Right-of-use assets are

depreciated over the shorter period of lease term and the useful life of the underlying asset. The

depreciation starts at the commencement date of the lease.

The Group applies NZ IAS 36: Impairment of Assets to determine whether a right-of-use asset is impaired

and accounts for any identified impairment loss as described in the 'property, plant and equipment' policy.

3.9. Property, plant and equipment

Property, plant and equipment are stated at cost less accumulated depreciation and accumulated

impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values, over their useful

lives using the diminishing value method. The estimated useful lives, residual values and depreciation

method are reviewed at the end of each reporting period, with the effect of any changes in estimate

accounted for on a prospective basis.

The following depreciation rates are used in the calculation:

Plant, vehicles and equipment 6% - 67%

Office equipment and furniture 10% - 50%

Leasehold improvements 6% - 25%

An item of property, plant and equipment is derecognised upon disposal or when no future economic

benefits are expected to arise from the continued use of the asset. Any gain or loss arising on the disposal

or retirement of an item of property, plant and equipment is determined as the difference between the

sales proceeds and the carrying amount of the asset and is recognised in profit or loss.

3.10. Assets held for sale

Biological assets held for sale are measured at fair value less costs to sell. Other non‑current assets

classified as held for sale are measured at the lower of carrying amount and fair value less costs to sell.

Non‑current assets are classified as held for sale if their carrying amount will be recovered through a sale

transaction rather than through continuing use. This condition is regarded as met only when the sale is

highly probable and the asset is available for immediate sale in its present condition. The Group must be

committed to the sale which should be expected to qualify for recognition as a completed sale within one

year from the date of classification.

3.11. Intangible assets

Acquired intangible assets with finite useful lives are carried at cost less accumulated amortisation and

accumulated impairment losses. Amortisation is recognised on a straight-line basis over their estimated

useful lives. The estimated useful life and amortisation method are reviewed at the end of each reporting

period, with the effect of any changes in estimate being accounted for on a prospective basis. Intangible

assets with indefinite useful lives that are acquired separately are carried at cost less accumulated

impairment losses.

The following amortisation rates are used in the calculation:

Customer relationship 12.5%

Website 50%

Trademarks & domains indefinite useful life

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




10

3.12. Financial instruments

Financial assets and financial liabilities are recognised in the Consolidated Statement of Financial Position

when the Group becomes a party to the contractual provisions of the instruments.

Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are

directly attributable to the acquisition or issue of financial assets and financial liabilities are added to or

deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial

recognition.

3.13. Financial assets

Financial assets are measured at amortised cost on the basis that the Group’s business model for

managing financial assets and the contractual cash flow characteristics of the financial assets. The Group

classifies its financial assets as at amortised cost only if both of the following criteria are met:

• the asset is held within a business model whose objective is to collect the contractual cash flows: and

• the contractual terms give rise to cash flows that are solely payments of principal and interest.

Financial assets at amortised costs

The Group holds receivables with the objective to collect the contractual cash flows, the cash flows are

solely payments of principal and interest, and therefore measures them subsequently at amortised cost

using the effective interest method, less impairment provisions.

The Group’s financial assets at amortised cost include cash and cash equivalents, short term deposits and

trade receivables. Cash and cash equivalents include cash in hand and deposits held at call with banks.

Impairment of financial assets at amortised cost

The Group recognises a loss allowance for expected credit losses on trade receivables. The amount of

expected credit losses is updated at each reporting date to reflect changes in credit risk since initial

recognition of the respective financial instrument.

The Group recognises lifetime expected credit losses for trade receivables. The expected credit losses on

these financial assets are estimated using a provision matrix based on the Group’s historical credit loss

experience, adjusted for factors that are specific to the debtors, general economic conditions and an

assessment of both the current as well as the forecast direction of conditions at the reporting date,

including time value of money where appropriate.

3.14. Financial liabilities

Financial liabilities (including trade, other payables and borrowings) are subsequently measured at

amortised cost using the effective interest method. The effective interest method is a method of calculating

the amortised cost of a financial liability and of allocating interest expense over the relevant period. The

effective interest rate is the rate that exactly discounts estimated future cash payments (including all fees

and points paid or received that form an integral part of the effective interest rate, transaction costs and

other premiums or discounts) through the expected life of the financial liability, or (where appropriate) a

shorter period, to the net carrying amount on initial recognition.

3.15. Segment reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief

operating decision maker. The chief operating decision maker, who is responsible for allocating resources

and assessing performance of the operating segments, has been identified as the Board of Directors.

3.16. Foreign currency translation

Foreign currency transactions are translated into the functional currency using the exchange rates

prevailing at the dates of the transactions.

At the end of each reporting period, monetary items denominated in foreign currencies are retranslated at

the rates prevailing at that date. Non-monetary items that are measured in terms of historical cost in a

foreign currency are not retranslated.

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




11

Exchange differences on monetary items are recognised in the profit or loss in the period in which they

arise.

For the purpose of presenting consolidated financial statements, the assets and liabilities of the Group’s

foreign operations are translated at exchange rates prevailing on the reporting date. Income and expense

items are translated at the average exchange rates for the period, unless exchange rates fluctuate

significantly during that period, in which case the exchange rates at the date of transactions are used.

Exchange differences arising, if any, are recognised in other comprehensive income and accumulated in a

foreign exchange translation reserve.

3.17. Share capital

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares

are shown in equity as a deduction, net of tax, from the proceeds.

3.18. Share based payment transactions

For equity-settled share-based payments where the goods or services acquired from non-employees can

be measured reliably, then the goods or services are measured directly at their fair value. If goods or

services cannot be measured reliably, or for transactions with employees, the goods or services are

measured indirectly, i.e. with reference to the fair value of equity instruments granted.

The fair value determined at the grant date of the equity-settled share-based payments is expensed on a

straight-line basis over the vesting period, based on the Group’s estimate of equity instruments that will

eventually vest, with a corresponding increase in equity.

At the end of each reporting period, the Group revises its estimate of the number of equity instruments

expected to vest. The impact of the revision of the original estimates, if any, is recognised in profit or loss

such that the cumulative expense reflects the revised estimate, with a corresponding adjustment to the

share-based payments reserve.

3.19. Borrowing costs

Borrowing costs are capitalised, net of interest received on cash drawn down yet to be expended when

they are directly attributable to the acquisition, contribution or production of an asset that necessarily takes

a substantial period of time to get ready for its intended use or sale.

3.20. Application of new and revised International Financial Reporting Standards

The Group has not early adopted any standards, interpretations or amendments that have been issued

but are not yet effective. Early adoption of these new standards, interpretations or amendments would not

have had a material impact on the financial result or financial position of the Group.

4. Critical accounting estimates and judgements

In the application of the Group’s accounting policies, which are described in note 3, the directors of the

Group are required to make judgements, estimates and assumptions about the carrying amounts of

assets and liabilities that are not readily apparent from other sources. The estimates and associated

assumptions are based on historical experience and other factors that are considered to be relevant.

Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting

estimates are recognised in the period in which the estimate is revised if the revision affects only that

period, or in the period of the revision and future periods if the revision affects both current and future

periods. Below are the critical accounting judgements.

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




12

4.1. Going concern

The consolidated financial statements have been prepared on a going concern basis, which assumes that

the Group has the intention and ability to continue its operations for the foreseeable future.

The Group incurred an after-tax loss of $12.97 million in the year to 30 June 2023 (15 month period to

30 June 2022: $19.54 million loss). The Group’s net cash outflows from operating activities during the year

was $5.56 million (15 months to 30 June 2022: $11.73 million net cash outflow).

At the reporting date the Group had cash of $0.9 million (2022: $5.4 million), working capital of $9.0 million

(2022: $22.1 million) and net assets of $11.9 million (2022: $24.1 million).

As at 30 June 2023, the Group had bank loans of $7.0 million (2022: $7.0 million), and $5.4 million was

payable to the previous owners of King Honey under a subordinated note (2022: $5.2 million) which, as at

the reporting date, was due for payment to the previous owners of King Honey in June 2024.

The Group’s banker, Bank of New Zealand, has confirmed that it will keep the Group’s existing bank

facilities in place (refer note 21) subject to further review no later than 31 August 2024 in conjunction with

the FY24 audited financial statements and FY25 budget. The facilities include an unused overdraft of $5

million. The facilities will remain on an interest only basis until 31 August 2024. The requirement for an

amortisation programme will be considered at that time in conjunction with the FY25 budget. The bank

also confirmed the continued suspension of earnings-related covenants until 31 August 2024.

On 28 August 2023, the Jarvis Trust has agreed to extend the repayment date of the subordinated note

for nine months to 31 March 2025 (refer note 21). A condition of this extension is that the Group cannot

increase its indebtedness to the BNZ above $9.5 million without the consent of the Jarvis Trust.

The Directors are satisfied that based on their review of the Group’s current financial forecasts,

confirmation from the Group’s banker of the existing facilities, and the extension agreement with Jarvis

Trust, that, during the 12 months after the date of signing these consolidated financial statements, there

will be adequate cash flows available to meet the financial obligations of the Group as they arise. The

Directors acknowledge that whilst the Group continues to build commercial relationships with new and

existing customers future looking forecasts are inherently uncertain. The Directors consider the overdraft

facility available to the Group (as modified by the Jarvis Trust condition) provide it with sufficient headroom

should it be required if sales or cost forecasts are not achieved.

The considered view of the Board is that, after making due enquiries and considering relevant factors,

there is a reasonable expectation that the Group will have access to adequate resources and

commitments from its borrowers, that will enable it to meet its financial obligations for the foreseeable

future.

For this reason, the Board considers the adoption of the going concern basis in preparing the consolidated

financial statements for the year ended 30 June 2023 to be appropriate. The Board has reached this

conclusion having regard to circumstances which it considers likely to affect the Group during the period of

at least one year from the date of approval of these consolidated financial statements, and to

circumstances which it considers will occur after that date which will affect the validity of the going concern

basis.

4.2. Fair value of inventory at harvest

The deemed cost for the Group’s agricultural produce (honey) inventory is fair value at harvest less

estimated point-of-sale costs. Fair value is determined by reference to market prices for honey.

Judgement is required to determine the market price of the honey at harvest based upon each drum’s

tested chemical markers (refer note 14).

4.3. Impairment of customer relationship asset

The cash‑generating unit to which the customer relationship asset has been allocated is tested for

impairment when there is an indication that the unit may be impaired. The Board has undertaken value in

use impairment testing and reviewed sensitivity analysis relating to the carrying value of the customer

relationship asset. Judgement is required in determining the extent to which there has been an impairment

in value (refer note 19.1).

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




13

4.4. Inventory net realisable value

Inventories are carried at the lower of cost and net realisable value. Management has identified that based

on near term forecast demand there is currently excess inventory held and therefore there may be issues

in achieving the carrying value of this inventory. They have estimated this excess quantity by grade of

honey and have considered its net realisable value by reference to the likely manner in which it will be

used. There is judgement involved in these estimates (refer note 12).

4.5. Fair value of biological assets

Biological assets are measured at fair value less point-of-sale costs. The fair value of biological assets is

assessed on an annual basis post-harvest, which involves reviewing the number of operational hives in

use and referencing market prices for hives. Judgement is required to determine the fair value of hives

(refer note 15).

4.6. Fair value of biological work in progress

Biological assets are measured at fair value less point-of-sale costs. The growth in the biological work in

progress in the period from harvest to 30 June cannot be reliably measured at fair value due to the

variables in hive growth and honey production between harvest and the reporting date. Therefore, as

required under NZ IAS 41: Agriculture, the cost of agricultural activity (beekeeping costs) in the period to

30 June has been capitalised as biological work in progress to account for this growth (refer note 14).

4.7. Deferred tax

Judgement is exercised in determining the timing and extent of recognition of the benefit of tax losses.

The benefit of tax losses can be recognised as an asset if its recovery is ‘probable’ (more likely than not).

In the absence of any track record of profitability, convincing evidence is needed of how the losses will be

recovered in the future, before any deferred tax asset is recognised. At 30 June 2023 the Group has

recognised the benefit in respect of the tax losses generated to the extent they offset a deferred tax

liability (refer note 8).

4.8. Accounting for leases

Judgement is required in determining whether it is reasonably certain that an extension option will be

exercised. The Group considers all relevant factors that create an economic incentive for it to exercise the

extension. After the commencement date, the Group reassesses the lease term if there is a significant

event or change in circumstances that is within its control and affects its ability to exercise or not to

exercise the option to extend (refer note 17).

The Group has included the extension period as part of those premises leases where it is reasonably

certain an extension option will be exercised.

5. Revenue


20232022

(12 months)(15 months)

NZ$000NZ$000

2,7813,260

Less marketing services provided by customers(1,318)(538)

Revenue from sale of health and wellbeing products1,4632,722

Revenue from sale of honey products5,8185,022

Revenue from agency services602529

Total revenue7,8838,273

Revenue from sale of health and wellbeing products before marketing

services provided by customers

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




14

The details above disaggregate the Group's revenue from contracts with customers into primary markets,

and major product and service lines.

Revenue was generated from the following geographical regions:


Revenue is allocated geographically based upon the jurisdiction in which the revenue is recognised for

taxation purposes.

6. Expenses

The loss for the year includes the following expenses.


20232022

(12 months)(15 months)

NZ$000NZ$000

6,4747,842

USA1,147-

Europe262431

Total revenue7,8838,273

New Zealand

20232022

Note(12 months)(15 months)

NZ$000NZ$000

Salaries(4,380)(7,898)

Employer kiwisaver contributions(106)(163)

Directors' fees29(470)(538)

Accounting and consulting(79)(125)

Shareholder expenses(40)(90)

Depreciation and amortisations:

Depreciation of property, plant and equipment16(600)(986)

Depreciation of right of use assets17.1(421)(695)

Amortisation of customer relationship asset19(1,083)(1,084)

Amortisation of other intangible assets19(3)(7)

(2,107)(2,772)

Depreciation and amortisation are allocated as follows:

Capitalised to biological WIP576647

Included in the operating loss(1,531)(2,125)

Finance expenses:

Interest on lease liabilities26(17)(62)

Interest on borrowings26(577)(579)

(594)(641)

Auditor's remuneration:

For the current year audit(157)(106)

For the prior year audit-(1)

Corporate finance service fee(11)-

For tax advice and returns-(9)

For general accounting advice-(5)

Total auditor's remuneration(168)(121)

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




15

7. Segment information

The Group:

• produces, sells, and markets health and wellbeing products (‘sale of goods’ segment) or acts as an

agent on behalf of other health and wellbeing suppliers (‘agency services’ segment); and

• produces premium manuka honey (‘honey’ segment).

The Group has identified its operating segments based on the internal reports reviewed and used by the

Chief Operating Decision Maker (‘CODM’), being the Board of Directors, in assessing the Group’s

performance and in determining the allocation of resources.

The ‘Operating EBITDA’ measure is stated after depreciation and amortisation capitalised to biological

WIP (note 6).

Head office expenses include costs related to the NZX listing.




Sale of AgencyHoneyHeadTotal

goodsservicesoffice

NZ$000NZ$000NZ$000NZ$000NZ$000

2,7816025,818-9,201

(1,318)---(1,318)

Total external revenue1,4636025,818-7,883

Total inter-segment revenue-----

Total operating EBITDA(2,365)(161)(1,228)(1,392)(5,146)

Finance income--134

Finance expenses--(591)(3)(594)

Amortisation of customer relationship

asset--(1,083)-(1,083)

Depreciation and amortisation(8)(3)(339)(98)(448)

Acquisition expenses---(115)(115)

Fair value loss on harvested honey--(2,223)-(2,223)

Fair value loss on biological assets--(544)-(544)

Restructuring costs--(337)-(337)

Write down of assets held for sale--(128)-(128)

Impairment of customer relationship

asset--(2,360)-(2,360)

Net loss before taxation(2,373)(164)(8,832)(1,605)(12,974)

Income tax benefit-----

Net loss for the year(2,373)(164)(8,832)(1,605)(12,974)

12 months to 30 June 2023

Revenue before marketing services

provided by a customer

Less marketing services provided by

customers

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




16





7.1. Information about major customers

For the 12 months ended 30 June 2023 there were 2 customers who individually accounted for more than

10% of the Group's total sales (15 months ended 30 June 2022: 2 customers). Sales to these customers

were $2,087,994 and $1,308,287 (2022: $2,011,161 and $1,852,980). These customers purchased goods

or agency services.


Sale of AgencyHoneyHeadTotal

goodsservicesoffice

NZ$000NZ$000NZ$000NZ$000NZ$000

3,2605295,022-8,811

(538)---(538)

Total external revenue2,7225295,022-8,273

Total inter-segment revenue-----

Total operating EBITDA(1,913)(310)(1,881)(1,548)(5,652)

Finance income--61319

Finance expenses--(633)(8)(641)

Amortisation of customer relationship

asset--(1,084)-(1,084)

Depreciation and amortisation(20)(8)(889)(124)(1,041)

Acquisition expenses---(368)(368)

Fair value loss on harvested honey--(1,724)-(1,724)

Fair value loss on biological assets--(720)-(720)

Restructuring costs--(494)-(494)

Write down of assets held for sale--(543)-(543)

Impairment of goodwill--(9,120)-(9,120)

Impairment of customer relationship

asset--(780)-(780)

Net loss before taxation(1,933)(318)(17,862)(2,035)(22,148)

Income tax benefit--2,604-2,604

Net loss for the year(1,933)(318)(15,258)(2,035)(19,544)

15 months to 30 June 2022

Revenue before marketing services

provided by a customer

Less marketing services provided by

customers

Sale of AgencyHoneyHeadTotal

goodsservicesoffice

NZ$000NZ$000NZ$000NZ$000NZ$000

Segment assets3,49524322,48273026,950

Segment liabilities69512313,63956015,017

Sale of AgencyHoneyHeadTotal

goodsservicesoffice

NZ$000NZ$000NZ$000NZ$000NZ$000

Segment assets2,25514731,5905,46439,456

Segment liabilities3964314,47144715,357

2022

2023

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




17

8. Taxation

8.1. Income tax recognised in profit or loss

The analysis of the income tax expense is as follows:



8.2. Reconciliation of income tax expense

The charge for the year can be reconciled to the loss before income tax as follows:



8.3. Deferred tax



20232022

(12 months)(15 months)

NZ$000NZ$000

Current income tax

Current income tax charge--

Deferred tax-(2,604)

Total income tax expense/(benefit) recognised in the current year-(2,604)

20232022

(12 months)(15 months)

NZ$000NZ$000

Loss before income tax(12,974)(22,148)

Current year tax at the tax rate of 28% (2022: 28%)(3,633)(6,201)

Non-deductible expenses1882,868

Current tax losses not recognised3,445729

Income tax expense/(benefit)-(2,604)

NZ$000NZ$000NZ$000NZ$000

2023

Deferred tax assets/(liabilities) in relation to:

Customer relationship asset(2,082) 964 - (1,118)

Inventory fair value adjustments1,472 (109) - 1,363

Fair value loss on harvested honey483 526 - 1,009

Write down of assets held for sale152 (116) - 36

Other133 (112) - 21

Deferred tax assets not recognised(2,240) (189) - (2,429)

Tax losses offset against deferred tax liability2,082 (964) - 1,118

- - - -

Opening

balance

Recognised

in loss

Acquisition of

subsidiaries

Closing

balance

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




18




The Group did not recognise deferred income tax assets in relation to the losses disclosed above except

to the extent they offset the deferred tax liability. The losses can be carried forward against future income

subject to meeting the requirements of income tax legislation including those relating to shareholder

continuity and business continuity (note 4.7).

9. Earnings per share


At 30 June 2023, there were no financial instruments that carried any shareholder dilution rights that were

considered to be dilutive (2022: none). The 1,000,000 share options on issue in 2022 (refer note 24) were

not considered to be dilutive due to the Group’s loss.


2022

Deferred tax assets/(liabilities) in relation to:

Customer relationship asset- 522 (2,604) (2,082)

Inventory fair value adjustments at acquisition- (14) 1,486 1,472

Fair value loss on harvested honey- 483 - 483

Write down of assets held for sale- 152 - 152

Other- 54 79 133

Deferred tax assets not recognised- (675) (1,565) (2,240)

Tax losses offset against deferred tax liability- 2,082 - 2,082

- 2,604 (2,604) -

20232022

NZ$000NZ$000

Tax losses

27,03914,735

Potential tax benefit @ 28%7,5714,126

Tax losses for which no deferred tax asset has been recognised

20232022

(12 months)(15 months)

Basic and diluted earnings/(loss) per share (NZ$)(0.009)(0.029)

Loss from continuing operations (NZ$000)(12,974)(19,544)

1,525,112664,695

The losses and weighted average number of ordinary shares used in the calculation of loss per share are as

follows:

Weighted average number of ordinary shares used in the calculation of

basic and diluted earnings per share ('000)

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




19

10. Cash and cash equivalents


The carrying amount for cash and cash equivalents equals the fair value. Cash balances are on call and

earn no interest.

11. Trade and other receivables



There has been no expected credit loss impairment to profit or loss in the period (2022: none).


The Group’s trade receivables aging is as follows:



The standard credit period on sales of goods is 30 or 60 days on the provision of the sale of goods or

rendering of agency services.

In determining the recoverability of a trade receivable, the Group considers any change in the credit

quality of the trade receivable from the date credit was initially granted up to the end of the reporting

period. The Group has 2 main customers who are both assessed as creditworthy. The Group maintains

close working relationships with these customers. The Group does not hold any collateral over these

balances.

The Group determines the expected credit losses on receivables by using a provision matrix, estimated

based on historical credit loss experience based on the past due status of the debtors, adjusted as

appropriate to reflect current conditions and estimates of future economic conditions.

Other Receivables includes amounts due from the sale of assets. These are repayable in instalments over

periods of up to 2 years.

20232022

NZ$000NZ$000

Cash at bank and on hand9135,370

9135,370

20232022

NZ$000NZ$000

Trade receivables1,660913

Other receivables5115

GST receivable41112

Prepayments231169

Total trade and other receivables2,4431,199

NZ$000

CurrentLess than 30

days past due

30 to 60 days

past due

More than 60

days past due

Total

2023

Trade receivables

675551503841,660

Loss allowance

-----

2022

Trade receivables

736872367913

Loss allowance

-----

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




20

12. Inventories


No inventory was written off to profit and loss in the period (2022: nil). Inventory expensed in the period

was $4,767,197 (2022: $4,899,517).

The Group’s inventory net realisable value provision at 30 June 2023 was $2.6 million (2022: $3.0 million).

The change in the provision was reversed to profit or loss in the year upon the sale of the related

inventory.

13. Assets held for sale





20232022

NZ$000NZ$000

Raw materials10,77713,069

Finished goods2,6863,119

Packaging materials1,296605

14,75916,793

20232022

NZ$000NZ$000

Property, plant and equipment93450

Biological assets-613

93 1,063

20232022

NZ$000NZ$000

At 1 July

1,063 -

Reclassified from property, plant & equipment (note 16):

- cost335 744

- accumulated depreciation(70) (104)

Write down of assets held for sale(61) (190)

Net book value reclassified from property, plant & equipment204 450

Reclassified from biological assets (note 15)302 965

Write down of assets held for sale(67) (352)

Net book value reclassified from biological assets235 613

Sale of assets(1,409) -

Balance at 30 June

93 1,063

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




21

14. Biological work in progress


15. Biological assets


The bees biological assets consist of hives and nucs.



The Group is exposed to some risks related to owning bees, primarily the risk of damage from climatic

changes and diseases. The Group has processes in place aimed at monitoring and mitigating those risks,

through hiring of experienced beekeepers, the intensive maintenance of beehives and disease prevention

programmes.

Fair value hierarchy

The Group’s bees are level 3 on the fair value hierarchy, being calculations for which inputs are not based

on observable market data (unobservable inputs).

20232022

NZ$000NZ$000

At 1 July698-

Acquisition of subsidiaries-1,437

Current period beekeeping costs2,3497,239

Fair value loss on harvested honey(2,223)(1,724)

Honey recognised as inventory on harvest(683)(6,952)

Beekeeping costs related to next harvest160698

Beekeeping costs expensed due to restructure(141)-

At 30 June

160698

20232022

NZ$000NZ$000

Bees:

At 1 July1,598 -

Acquisition of subsidiaries-3,283

Reclassified to assets held for sale (note 13)(302) (965)

Fair value loss on biological assets(544) (720)

At 30 June

752 1,598

20232022

number ofnumber of

Hives:

At 1 July8,950 -

Acquisition of subsidiaries- 15,595

Reduction in operational hives(3,047)(2,995)

Hives classified as assets held for sale (note 13)(1,691)(3,650)

Hives included in biological assets at 30 June

4,212 8,950

Nucleus colonies (Nucs):

At 1 July- -

Acquisition of subsidiaries- 3,660

Reduction in operational nucs- (1,360)

Nucs classified as assets held for sale (note 13)- (2,300)

Nucs included in biological assets at 30 June

- -

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




22

The Group has valued the biological assets based on market sales price information and the Group’s own

sales of hives. The fair value per hive is $179 (2022: $179).

16. Property, plant and equipment



NZ$000NZ$000NZ$000NZ$000NZ$000

Cost:

At 1 April 2021

10 - 95 31 136

Additions

81 208 37 1 327

Acquisition of subsidiaries

3,731 968 62 335 5,096

Transferred to assets held for sale

(406) (338) - - (744)

Disposals

(2) (133) - - (135)

At 30 June 2022

3,414 705 194 367 4,680

Additions

31 - 4 - 35

Transferred to assets held for sale

(314) (21) - - (335)

At 30 June 2023

3,131 684 198 367 4,380

Accumulated depreciation:

At 1 April 2021(4) - (35) (6) (45)

Depreciation expense

(660) (210) (68) (48)

(986)

Transferred to assets held for sale

41 63 - -

104

Disposals

- 35 - -

35

At 30 June 2022

(623) (112) (103) (54) (892)

Depreciation expense

(410) (113) (36) (41)

(600)

Transferred to assets held for sale

59 11 - -

70

At 30 June 2023

(974) (214) (139) (95) (1,422)

Carrying amount:

At 30 June 2023

2,157 470 59 272 2,958

At 30 June 2022

2,791 593 91 313 3,788

At 1 April 2021

6 - 60 25 91

Plant &

equipment

Office

equipment

& furniture

Leasehold

improvements Total Vehicles

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




23

17. Leases

17.1. Right-of-use asset


The Group leases warehouse and administration premises, and land used for hive placements.


17.2. Lease liability


Premises Hive

placements

Total

NZ$000NZ$000NZ$000

Cost:

At 1 April 2021226 - 226

Additions296 313 609

Acquisition of subsidiaries934 1,071 2,005

Lease modifications(82) (626) (708)

At 30 June 20221,374 758 2,132

Additions174 186 360

Acquisition of subsidiaries- - -

Lease modifications(332) (224) (556)

At 30 June 2023

1,216 720 1,936

Accumulated amortisation:

At 1 April 2021(50) - (50)

Depreciation expense(371) (324) (695)

At 30 June 2022(421) (324) (745)

Depreciation expense(284) (137) (421)

At 30 June 2023

(705) (461) (1,166)

Carrying Amount:

At 30 June 2023511 259 770

At 30 June 2022953 434 1,387

At 1 April 2021176 - 176

20232022

NZ$000NZ$000

Maturity analysis - contractual undiscounted cash flows

Up to one year356381

One to two years335526

Two to five years156492

More than five years-77

Total undiscounted lease liabilities at 30 June8471,476

Lease liabilities included in the Consolidated Statement of Financial Position

Current334316

Non-current4721,041

8061,357

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




24

At the reporting date the Group had 4 property leases with an average remaining term of 2.6 years (2022:

3.75 years). The Group also had 7 land access leases with an average remaining term of 1.86 years

(2022: 0.75 years).

The average IBR rate is 3.6% (2022: 3.63%).

Short term lease expenses included in operating loss were $1,122,000 (2022: $1,122,000).

18. Goodwill


19. Other intangible assets



20232022

NZ$000NZ$000

Balance at 1 July--

Recognised on acquisition of subsidiary-9,120

Impairment losses for the period (note 19.1)-(9,120)

Balance at 30 June

--

Customer

relationship Website

Trademarks

& domains Total

NZ$000NZ$000NZ$000NZ$000

Cost:

At 1 April 2021- 26 61 87

Additions

- - 23 23

Acquisition of subsidiaries

9,300 - - 9,300

At 30 June 2022

9,300 26 84 9,410

Additions

- - 12 12

At 30 June 2023

9,300 26 96 9,422

Accumulated amortisation and impairment:

At 1 April 2021

- (14) -

(14)

Amortisation expense

(1,084) (7) -

(1,091)

Impairment of intangible asset (note 19.1)

(780) - -

(780)

At 30 June 2022

(1,864) (21) - (1,885)

Amortisation expense

(1,083) (3) -

(1,086)

Impairment of intangible asset (note 19.1)

(2,360) - -

(2,360)

At 30 June 2023

(5,307) (24) - (5,331)

Carrying Amount:

At 30 June 20233,993 2 96 4,091

At 30 June 20227,436 5 84 7,525

At 1 April 2021- 12 61 73

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




25

19.1. Impairment testing for cash-generating units containing goodwill and the customer

relationship asset

Given the financial performance of the Honey segment did not meet internal forecast expectations, the

Board undertook a value in use impairment test at 30 June 2023 and reviewed sensitivity analysis relating

to the carrying value of the customer relationship asset (2022: impairment test as at 31 March 2022 to

assess carrying value of the goodwill and customer relationship assets).

The Group considered the future cash flows arising out of the sale of Manuka Honey through the Honey

segment. As a result of the completion of discounted cashflow modelling, the Board assessed the value of

the Honey CGU as $21.1 million (2022: $29.0 million). The Board concluded that it was appropriate for the

Group to recognise impairments in value in the goodwill and the customer relationship asset arising from

the King Honey acquisition as set out below:


Value in use was determined by discounting the future cash flows generated from the continuing use of

the CGU and was based on the following key assumptions:


Cash flows were projected on actual operating results, the 12-month budget, multi-year forecasts and

business plan.

The discount rate selected reflects the level of uncertainty in relation to the future revenue from the Honey

CGU.

The growth rate applied in years 2029-2037 (years 6 to 14 in the model) to revenue is 3% and to costs is

2-3%. These rates reflect the long-term growth rates of the markets in which the revenues are earned and

the costs expended. These years have been included in the calculation to forecast a tax outflow in the

terminal year where the terminal value has been derived, as existing tax losses are expected to be utilised

against taxable profits in earlier years.

20. Trade and other payables


Trade and other payables are unsecured, non-interest bearing and usually paid within 45 days of

recognition. Therefore, the carrying value of creditors and other payables approximates their fair value.

20232022

NZ$000NZ$000

Impairment losses:

Impairment of customer relationship asset(2,360)(780)

Impairment of goodwill (note 18)-(9,120)

(2,360)(9,900)

20232022

Years assessed in cash projections

2024 - 20282023 - 2027

Anticipated annual revenue growth3% - 20%26% - 39%

Anticipated annual overhead expense increase3%2%

Pre-tax discount rate18.2%16.5%

Terminal growth rate3%3%

20232022

NZ$000NZ$000

Trade payables946482

Accruals593626

Other payables238658

1,7771,766

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




26

21. Borrowings


The Group has two bank loans from the Bank of New Zealand. A customised average rate loan facility

(CARL) of $2,908,420 (2022: $3,015,980) and a fixed rate loan of $4,125,809 (2022: $4,286,125). The

loans were taken out on 30 June 2021 and are for five years, ending 29 June 2026. The loans are secured

over all property of Me Today Manuka Honey Limited, the parent company of King Honey Limited and a

subsidiary of Me Today Limited.

The CARL facility monthly repayments consist of a fixed principal repayment plus interest based on a

floating rate that is adjusted monthly. The average annual interest on the CARL facility rate during the

reporting period was 6.58% (2022: 3.91%). Interest on the fixed rate loan is fixed at 2.51% per annum and

the loan is repaid by monthly instalments over the term of the loan. The Group had a repayment holiday

from June 2022 to August 2023. The bank has also agreed to suspend its earnings-related covenants until

31 August 2023 at which stage covenants will be re-assessed in line with the FY24 budget. The Group

was compliant with applicable covenants at 30 June 2023.

Under the terms of the sale and purchase agreement for the acquisition of King Honey it was agreed that

$5,000,000 of the purchase price would be left payable to the vendors, the Jarvis Trust, as a subordinated

note. As at 30 June 2023 the subordinated loan was repayable in three years from the acquisition date of

30 June 2021 and is classified in the Consolidated Statement of Financial Position as a current liability.

The note is secured over all property of Me Today Manuka Honey Limited. This security interested ranks

behind any security interest in favour of the Bank of New Zealand pursuant to the bank loan agreements

noted above, but ahead of any other indebtedness of Me Today Manuka Honey Limited. Subsequent to

the reporting date the parties have agreed to extend the repayment date of the subordinated note for nine

months to 31 March 2025. A condition of this extension is that the Group cannot increase its indebtedness

with the BNZ above $9.5 million without the consent of the Jarvis Trust. Interest of 4% per annum is

payable annually in arrears until 30 June 2024. Interest of 8% per annum is payable from 1 July 2024

onwards. The extension is subject to Me Today obtaining shareholder approval under NZX Listing Rule

5.2 (related party transactions) or a waiver of that rule.

The Group currently has available overdraft facilities of $5 million (2022: $5 million). The interest rate on

this facility at 30 June 2023 was 9.91% per annum.


20232022

NZ$000NZ$000

Banks loans7,0347,034

Subordinated note5,4005,200

12,43412,234

Current7,248942

Non-current5,18611,292

12,43412,234

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




27

22. Share capital



On 6 July 2022 the Company issued 75,264,609 fully paid ordinary shares for $752,646 as a part

placement of the shortfall from its rights issue undertaken in June 2022. The Company agreed with MTL

Securities Limited to contemporaneously reclassify 39,051,043 of its non-voting shares as quoted shares

to preserve MTL Securities Limited’s holding and control of voting rights at 34.16%. The new shares

issued have consequentially reduced MTL Securities Limited’s economic rights to 44.86%.

On 28 June 2023 the Company issued 17,715,461 fully paid ordinary shares in the favour of BB

Promotions Limited, Sarah Walker, independent directors and a non-executive director. Shares issued to

BB Promotions Limited and Sarah Walker are in accordance with the terms of the relevant agreements for

promotional services.

All voting ordinary shares on issue are fully paid and rank equally with one vote attached to each share.

All non-voting ordinary shares are fully paid.

23. Share based payments reserve


The Group has entered into two Ambassador Agreements for the provision of promotional services. A

portion of the consideration payable for the promotional services is settled by the issue of shares. For one

ambassador, who is a related party, shares are issued twice yearly with a total of 1,244,444 ordinary

shares to be issued each year at an issue price of $0.09 per share. 1,111,111 shares are to be issued

annually under an agreement with a three-year term. For the other ambassador 133,333 shares are

issued annually under an agreement with a two-year term.

All share-based payments were included in promotional expenses.


Voting

ordinary

shares

Non-voting

ordinary

shares

Voting

ordinary

shares

Non-voting

ordinary

shares

'000'000'000'000

Number of ordinary shares:

Ordinary shares as at 1 July1,163,697287,086412,278-

Issue of shares as settlement of purchase price--113,636-

Ordinary shares issued during the period92,980-924,903-

Ordinary shares reclassified as non-voting39,051(39,051)(287,086)287,086

Share buy back and cancellation--(34)-

Ordinary shares as at reporting date1,295,728248,0351,163,697287,086

20232022

20232022

NZ$000NZ$000

Balance as at 1 July77110

Share options granted (note 24)-30

Share options expired (note 24)(13)(26)

Share based payments for promotional services95140

Shares issued in period(159)(177)

Balance at reporting date

-77

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




28

24. Share options


At 30 June 2022 BB Promotions Limited, a related party to the Group (refer note 29.4), held options on

1,000,000 ordinary shares of the Company. Each option could be converted into one ordinary share of the

Company on exercise. No amounts were paid or payable by BB Promotions Limited on receipt of the

options. The options carried no rights to dividends and no voting rights. The options expired during the

2023 financial year.


25. Reconciliation of loss after taxation with cash flow from operating activities


Balance as at 1 July

1,000,000$0.093,000,000$0.09

Granted during the period----

Exercised during the period----

Expired during the period(1,000,000)$0.09(2,000,000)$0.09

Balance at 30 June

--1,000,000$0.09

20232022

Number of

Options

Weighted

average

exercise price

Number of

Options

Weighted

average

exercise price

20232022

NZ$000NZ$000

Share based payments are included in:

Promotional costs9530

30 Jun 2023 30 Jun 2022

(12 months)(15 months)

NZ$000NZ$000

Net loss after taxation(12,974)(19,544)

Adjustments for:

Depreciation and amortisation2,1072,771

Interest on lease liabilities1762

Interest on borrowings577579

Impairment of goodwill-9,120

Impairment of customer relationship asset2,360780

Acquisition costs114367

Fair value loss on biological assets544720

Write down of assets held for sale128543

Share-based payments209242

Income tax benefit-(2,604)

Movements in working capital

(Increase) / decrease in trade and other receivables(1,244)(778)

(Increase) / decrease in inventory2,034(15,859)

(Increase) / decrease in biological work in progress538(698)

Decrease / (increase) in taxation receivable26(12)

Increase / (decrease) in trade and other payables91,139

Movement in working capital on acquisition of subsidiaries-11,446

Net cash outflows from operating activities(5,555)(11,726)

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




29

26. Reconciliation of liabilities arising from financing activities





20232022

NZ$000NZ$000

Borrowings:

At 1 July

12,234-

Cash:

Proceeds from bank borrowings-8,500

Payment of principal on borrowings-(1,466)

Interest paid on borrowings(377)(379)

Non-cash:

On acquisition of subsidiaries

-5,000

Interest on borrowings577579

At 30 June

12,43412,234

20232022

NZ$000NZ$000

Lease liabilities:

At 1 July

1,357193

Cash:

Payment of lease liabilities principal(355)(742)

Interest paid on lease liabilities(17)(62)

Non-cash:

Lease liabilities recognised186609

On acquisition of subsidiaries-2,005

Lease modifications(382)(708)

Interest on lease liabilities1762

At 30 June

8061,357

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




30

27. Subsidiaries and other investments



All subsidiaries are domiciled in New Zealand, with the exception of Me Today EU Limited which is

domiciled in Ireland, Me Today UK Group Limited which is domiciled in England, Me Today USA Inc.

which is domiciled in the United States and Me Today Pty which is domiciled in Australia. All subsidiaries

have a reporting date of 30 June.

28. Financial instruments

The Group’s activities expose it to a variety of financial risks: market risk (including currency risk and

interest rate risk), credit and liquidity risk. The Group’s overall risk management programme focuses on

the unpredictability of financial markets and seeks to minimise potential adverse effects on its financial

performance.

Risk management is carried out under policies approved by the Board of Directors. The Board provides

written principles for overall risk management as well as policies covering specific areas such as interest

rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments.

The Group has entered into a number of non-derivative financial instruments all of which are classified as

financial assets and liabilities at amortised cost. The carrying values of these items approximate their fair

value and represent the maximum exposures for each type of financial instrument. They are listed as

follows:

NamePrincipal activity

20232022

Subsidiaries:

The Good Brand Company LimitedSale of health & wellbeing

products

100%100%

Me Today NZ LimitedProduction & sale of health &

wellbeing products

100%100%

Today LimitedNon-trading entity100%100%

Me Today EU LimitedSale of health & wellbeing

products

100%100%

Me Today UK Group LimitedSale of health & wellbeing

products

100%100%

Me Today Manuka Honey LimitedInvestment in King Honey

Limited

100%100%

King Honey LimitedSale of manuka honey products100%100%

Me Today AU Pty LimitedNon-trading entity100%100%

Manuka Wellness LimitedNon-trading entity100%100%

King Honey Health Products LimitedNon-trading entity100%100%

Pure Manuka NZ LimitedNon-trading entity100%100%

Bee Plus Manuka NZ LimitedNon-trading entity100%100%

Me Today USA Inc.Sale of health, wellbeing and

honey products

100%100%

Other investments:

Bee Plus New Zealand LimitedBrand ownership. Non trading15%15%

Equity holding

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




31


The fair value of cash and cash equivalents and trade receivables are determined to be equivalent to their

carrying value due to the short-term nature of these balances.



The fair value of trade payables and other liabilities, and the subordinated note, are determined to be

equivalent to their carrying value due to the short-term nature of these balances.

The fair value of the bank loans is $6,618,000 (2022: $6,728,000).

The Group does not have any derivative financial instruments (2022: nil).

28.1. Market risk

Market risk is the risk that changes in market prices, such as foreign exchange rates and interest rates will

affect the Group’s income or the value of its holdings of financial instruments. The objective of market risk

management is to manage and control the market risk exposures within acceptable parameters, while

optimising the return on risk. There is minimal market risk.

28.2. Cash flow and fair value interest rate risk

The Group’s interest rate risk arises from interest on borrowings at variable rates. The Group has no

interest-bearing cash and cash equivalent bank accounts.

The fixed rate bank loan and the subordinated note (see note 21) have interest rates that are fixed for the

life of the loan. The BNZ CARL is the only borrowing with a variable interest rate (see note 21). The

Group’s exposure to a change in interest rates is therefore currently limited to the borrowings under the

BNZ CARL facility. The table below shows the impact that a 1% movement in the current interest rate on

the BNZ CARL facility would have on the per annum interest expense.




Note20232022

NZ$000NZ$000

Financial assets at amortised cost

Cash and cash equivalents109155,370

Trade receivables111,660913

Other receivables11511-

Total financial assets3,0866,283

Note20232022

NZ$000NZ$000

Financial liabilities at amortised cost

Trade payables and other liabilities201,7771,766

Banks loans217,0347,034

Subordinated note215,4005,200

Total financial liabilities14,21114,000

FacilityInterest

balanceimpact

2023Rate (+/-1%)

NZ$000NZ$000

BNZ CARL facility2,90829/(29)

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




32

28.3. Credit risk

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument

fails to meet its contractual obligations and arises from cash and cash equivalents, deposits with banks

and the Group’s receivables from customers. The Group’s maximum credit risk is represented by the

carrying value of these financial assets. The credit risk associated with cash transactions and deposits is

managed through the Group’s policies that limit the use of counterparties to high credit quality financial

institutions.

28.4. Liquidity risk

Liquidity risk is the risk that the Group will not be able to meet its financial obligations as and when the fall

due. The Group’s liquidity risk management includes maintaining sufficient cash reserves to meet future

commitments. Refer to note 4.1 in relation to going concern.

The following table provides a maturity analysis of the Group’s remaining contractual cash flows relating to

financial liabilities. Contractual cash flows include contractual undiscounted principal and interest

payments.



28.5. Capital risk management

The Group’s objectives when managing capital are to safeguard their ability to continue as a going

concern, so that they can continue to provide returns to shareholders and benefits for other stakeholders

and to maintain an optimal capital structure that reduces the cost of capital.

29. Related parties

29.1. Directors

The names of persons who are directors of the Company are; Grant Baker (Chairman), Hannah Barrett,

Roger Gower, Michael Kerr, Richard Pearson, Stephen Sinclair, and Antony Vriens.

29.2. Key management personnel compensation

Key management personnel compensation is set out below. The key management personnel are all the

directors of the Company.

Directors were paid directors’ fees of $470,000 (15 months to 30 June 2022: $538,000). In the period to

30 June 2023 $70,214 of the remuneration due to the independent directors was settled by the issue of

1,312,266 shares in the Company (15 months to 30 June 2022: $71,572 by the issue of 1,312,266 shares

in the Company). At 30 June 2022 $14,062 was payable to the independent directors and was

subsequently settled by the issue of shares in the Company.

NZ$000NZ$000NZ$000NZ$000NZ$000NZ$000

Non-derivative financial liabilities

2023

Trade and other payables1,777 1,777 1,665 112 - -

Borrowings12,434 13,293 911 6,862 2,498 3,022

Lease liability806 927 242 122 335 228

15,017 15,997 2,818 7,096 2,833 3,250

2022

Trade and other payables1,766 1,766 1,766 - - -

Borrowings12,234 13,290 270 926 7,417 4,677

Lease liability1,357 1,389 386 166 421 416

15,357 16,445 2,422 1,092 7,838 5,093

Payable

2-5 years

Carrying

amount

Contractual

cash flows

Payable

0-6 months

Payable

6-12 months

Payable

1-2 years

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




33

At 30 June 2023 $9,104 was payable to Bakers Consultants Limited, a company owned by Grant Baker,

for directors fees (2022: nil).

At 30 June 2023 $6,563 was payable to Mei Mei Limited, a company owned by Richard Pearson, for

directors fees (2022: $7,000).

Michael Kerr received total remuneration of $250,000 in 2023 in his role as CEO (15 months to 30 June

2022: $281,000).

A company owned by Stephen Sinclair received $125,000 in consulting fees (15 months to 30 June 2022:

$156,250).

29.3. Related entities

MTL Securities Limited is an entity owned and controlled by M & N Kerr Holdings, of which Michael Kerr is

a director, and Velocity Capital, of which Grant Baker and Stephen Sinclair are directors. MTL Securities

Limited holds 34.16% of the voting ordinary shares, and 44.86% of the total voting and non-voting ordinary

shares in Me Today Limited.

29.4. Related party transactions

In the year to 30 June 2023, the Company issued 3,277,150 ordinary shares to each of Antony Vriens,

Hannah Barrett and Roger Gower and 6,117,346 to Richard Pearson, in part settlement of their directors’

remuneration. In the 15 months to 30 June 2022, the Company issued 965,613 ordinary shares to Antony

Vriens, Hannah Barrett and Roger Gower in part settlement of their directors’ remuneration.

The Company issued 712,575 ordinary shares to Roger Gower and 3,411,778 ordinary shares to Antony

Vriens as part of the retail offer to investors on 29 June 2022 for $7,126 and $34,118 respectively.

On 15 June 2020 the Company entered into an Ambassador Agreement with BB Promotions Limited for a

term of three years. BB Promotions Limited is a related party to the Group, as the shareholder and director

of BB Promotions Limited, B Barrett, is married to H Barrett, a director of the Company. Under the terms of

the agreement, BB Promotions Limited agreed to provide promotional services to the Company in

exchange for the payment of $50,000 per annum, the issue by the Company of ordinary shares to BB

Promotions Limited to the value of $100,000 per annum, and the granting of 3,000,000 options to

purchase ordinary shares in the Company (as detailed in notes 24). Share based payments for promotion

services shown in note 23 includes $62,500 in relation to the Ambassador Agreement with BB Promotions

Limited.

Hannah Barrett received $6,250 for providing marketing services to the Group (15 months to 30 June

2022: $18,750).

29.5. Share placement subscription agreement

On 26 November 2021, Me Today, the TW Jarvis (No. 1) Family Trust (“Jarvis Trust”) and MTL Securities

Limited (“MTL”) entered into a share placement subscription agreement under which the Jarvis Trust and

MTL agreed to invest additional cash of $6 million through a share placement, conditional upon

shareholder approval. The shares were issued at 8.8 cents per share, the same issue price for capital

raised as part of the King Honey acquisition and reflecting their respective shareholdings. MTL Securities

agreed to contribute $3.75 million and Jarvis Trust $2.25 million. Shareholders approved the share

placement on 18 March 2022.

On 22 March 2022 the Company issued 42,613,636 fully paid ordinary shares to MTL Securities Limited

and 25,568,182 fully paid ordinary shares to the trustees of TW Jarvis (No. 1) Trust.

Jarvis Trust is a substantial security holder in Me Today and is the previous vendor of King Honey Limited.

MTL is a substantial security holder, and the largest shareholder, in Me Today. MTL is an entity owned

and controlled by M & N Kerr Holdings, of which Michael Kerr is a director, and Velocity Capital, of which

Grant Baker and Stephen Sinclair are directors.

Me Today Limited
Notes to the Consolidated Financial Statements

For the year ended 30 June 2023




34

30. Contingent liabilities

There are no contingent liabilities as at 30 June 2023 (2022: nil).

31. Commitments

The Company had no commitments for future capital expenditure as at 30 June 2023 (2022: nil).

32. Events subsequent to reporting date

On 23 August 2023 the Group’s bank confirmed its continuance of existing facilities subject to further

review no later than 31 August 2024 in conjunction with the FY24 audited financial statements and FY25

budget. Facilities will remain on an interest only basis until 31 August 2024. The requirement for an

amortisation programme will be considered at that time in conjunction with the FY25 budget. The bank

also confirmed covenant requirements continue to be amended to extend the suspension of earnings-

related covenants until 31 August 2024.

Subsequent to the reporting date the Board has decided to further reduce beekeeping operations with a

view to reducing total hive numbers to below 2,000.

On 28 August 2023 the Group entered into an agreement with the Jarvis Trust to extend the repayment

date of the subordinated note for nine months to 31 March 2025. A condition of this extension is that the

Group cannot increase its indebtedness with the BNZ above $9.5m without the consent of the Jarvis

Trust. Interest of 4% per annum is payable annually in arrears until 30 June 2024. Interest of 8% per

annum is payable from 1 July 2024 onwards.


BDO Auckland


35


INDEPENDENT AUDITOR’S REPORT

TO THE SHAREHOLDERS OF ME TODAY LIMITED


Opinion

We have audited the consolidated financial statements of Me Today Limited (“the Company”) and its

subsidiaries (together, “the Group”), which comprise the consolidated statement of financial position as at 30

June 2023, and the consolidated statement of profit or loss and other comprehensive income, consolidated

statement of changes in equity and consolidated statement of cash flows for the year then ended, and notes to

the consolidated financial statements, including a summary of significant accounting policies.


In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the

consolidated financial position of the Group as at 30 June 2023, and its consolidated financial performance and

its consolidated cash flows for the year then ended in accordance with New Zealand equivalents to

International Financial Reporting Standards (“NZ IFRS”) and International Financial Reporting Standards

(“IFRS”).


Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (New Zealand) (“ISAs (NZ)”).

Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit

of the Consolidated Financial Statements section of our report. We are independent of the Group in

accordance with Professional and Ethical Standard 1 International Code of Ethics for Assurance Practitioners

(including International Independence Standards) (New Zealand) issued by the New Zealand Auditing and

Assurance Standards Board, and we have fulfilled our other ethical responsibilities in accordance with these

requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a

basis for our opinion.


In addition to audit services, our firm provided other services in the areas of corporate finance services. BDO

partners and staff also transact with the Group on normal trading terms throughout the year. The engagement

and trading transactions have not impaired our independence as auditor of the Group. We have no other

relationship with, or interests in, the Company or its subsidiaries.


Key Audit Matters

Key audit matters are those matters that, in our professional judgement, were of most significance in our

audit of the consolidated financial statements of the current period. These matters were addressed in the

context of our audit of the consolidated financial statements as a whole and in forming our opinion thereon,

and we do not provide a separate opinion on these matters.



Impairment of intangible assets



Key Audit Matter How The Matter Was Addressed in Our Audit

The Group had a customer relationship intangible

asset of $3.9m at 30 June 2023, which is required to

be assessed for impairment indicators as it is a non-

financial asset.


Given the financial performance of the Honey cash

generating unit did not meet internal forecast

expectations, management performed a formal

impairment test to determine the recoverable

amount of the cash generating asset.


We identified the calculation of the recoverable

amount as a key audit matter to our audit due to the

significance of the balance to the financial

statements and the key inputs and assumptions that

are subject to significant management judgement and

estimation uncertainty.


See note 19.1 to the financial statements.

• We obtained management's value in use

calculation prepared at 30 June 2023, and

critically evaluated the key inputs and

assumptions. The key inputs included forecast

revenue, gross margin, costs, working capital

assumptions, tax outflows and discount rate.

• We agreed the forecasts used to the

management approved budget.

• We obtained management’s discount rate

calculation, prepared by an external valuation

expert. We considered the objectivity and

competence of the expert.

• We engaged our internal valuation expert to

review the value in use calculation against

valuation industry techniques and the discount

rate used.

• We compared the carrying value of the assets to

the recoverable amount determined by the

impairment test that calculated the impairment

charge of $2.4m.


BDO Auckland


36



Inventory net realisable value



Key Audit Matter How The Matter Was Addressed in Our Audit

At the reporting date, management is required to

consider if the Group’s inventories are carried at the

lower of cost or net realisable value.


Management has identified that based on near term

forecast demand that there is currently excess

inventory held and that therefore there may be issues

in achieving the carrying value of this inventory.

They have estimated this excess quantity, by grade of

honey, and have considered its net realisable value

by reference to the likely manner in which it will be

used. Management recorded an inventory net

realisable value provision in this respect of $2.6m

(2022: $3.0m).


We identified the determination of the net realisable

value by management as a key audit matter to our

audit due to the significance of the balance to the

financial statements and the significant judgement

involved in determining these estimates.


See note 12 to the financial statements. The Group's

critical accounting estimate and judgement regarding

inventory net realisable value is disclosed in note 4.4

to the financial statements.

• We obtained management’s calculation of the

required net realisable value provision against

the carrying value of inventories. We re-

calculated the excess inventory by grade by

reference to quantity held and forecast demand

which was agreed to management approved

budgets.

• We obtained management’s rationale for the

expected use of this excess inventory and the

net realisable value provision held. We

challenged management with respect to their

rationale and on the existence of other

alternative uses for the inventories.

• We agreed the net realisable values used in the

management calculation to supporting

documentation and re-calculated the net

realisable value provision required.




Other Information

The directors are responsible for the other information. The other information comprises the Market

Announcement on the Me Today results for the year ended 30 June 2023 (but does not include the

consolidated financial statements and our auditor’s report thereon), which we obtained prior to the date of

this auditor’s report, and the Annual Report, which is expected to be made available to us after that date.


Our opinion on the consolidated financial statements does not cover the other information and we do not and

will not express any form of audit opinion or assurance conclusion thereon.


In connection with our audit of the consolidated financial statements, our responsibility is to read the other

information identified above and, in doing so, consider whether the other information is materially

inconsistent with the consolidated financial statements or our knowledge obtained in the audit, or otherwise

appears to be materially misstated.


If, based on the work we have performed on the other information that we obtained prior to the date of this

auditor’s report, we conclude that there is a material misstatement of this other information, we are required

to report that fact. We have nothing to report in this regard.


When we read the Annual Report, if we conclude that there is a material misstatement therein, we are

required to communicate the matter to the directors.


Directors’ Responsibilities for the Consolidated Financial Statements

The directors are responsible on behalf of the Group for the preparation and fair presentation of the

consolidated financial statements in accordance with NZ IFRS and IFRS, and for such internal control as the

directors determine is necessary to enable the preparation of consolidated financial statements that are free

from material misstatement, whether due to fraud or error.


In preparing the consolidated financial statements, the directors are responsible on behalf of the Group for

assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going

concern and using the going concern basis of accounting unless the directors either intend to liquidate the

Group or to cease operations, or have no realistic alternative but to do so.


BDO Auckland


37



Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a

whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report

that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an

audit conducted in accordance with ISAs (NZ) will always detect a material misstatement when it exists.

Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate,

they could reasonably be expected to influence the decisions of users taken on the basis of these consolidated

financial statements.


A further description of our responsibility for the audit of the financial statements is located on the External

Reporting Board’s website at:


https://www.xrb.govt.nz/standards-for-assurance-practitioners/auditors-responsibilities/audit-report-1.


This description forms part of our auditor’s report.


Who we Report to

This report is made solely to the Company’s shareholders, as a body. Our audit work has been undertaken so

that we might state those matters which we are required to state to them in an auditor’s report and for no

other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone

other than the Company and the Company’s shareholders, as a body, for our audit work, for this report or for

the opinions we have formed.


The engagement partner on the audit resulting in this independent auditor’s report is Chris Neves.





BDO Auckland

Auckland

New Zealand

29 August 2023

---

1

29 August 2023

Me Today results for the year ended 30 June 2023

Me Today Limited (NZX: MEE) today announced its audited Group results for the year ended 30 June

2023.

The Group recorded net revenue of $7.88m and a loss after tax of $12.97m. The operating EBITDA

loss was $5.15m after adding back non-recurring and non-cash items of $7.82m as explained further

below.

Gross revenue for the Group before the costs of marketing services provided by a customer was

$9.20m. This was split between the King Honey business at $5.82m, Me Today branded sales of

$2.78 and agency services revenue at $0.60m.

Given the large holding of Manuka honey, the Group decided to further reduce the size of its

beekeeping operation as announced to the market on 11 July 2023. Once the restructure is

complete the Beekeeping operation will have approximately 1,600 hives operating out of Turangi.

Together with the reduction in beekeeping, the business has continued to reduce expenditure across

its operation in line with its previously stated strategy. As described further below, the Group

continues to create sales opportunities across its three core brands. The sales activity comes from

new customers and repeat business with existing customers.

The Group continues to receive support of its lenders the Bank of New Zealand and the Jarvis Trust.

As part of the acquisition of the King Honey business, the vendor the Jarvis Trust is due repayment of

a $5m subordinated loan on 30 June 2024. The group has agreed with Jarvis Trust to extend the

repayment date of the Jarvis Trust loan to 31 March 2025, subject to all necessary approvals under

the NZX Listing Rules.

With the support of the lenders, the reduction in cost base and the forecast sales the Group believes

it has sufficient funding to meet operational requirements for the coming year. The Group will

continue to review its cost base and make necessary adjustments as required. It is also considering

funding alternatives to lower a part of its term debt which may include the sale of assets or raising

new capital.

As part of the year end audit process the group considered the carrying value of its intangible assets

given the continuing challenging market for selling Manuka honey. The result is the directors have

decided to make a further impairment by writing down the value of the intangible assets associated

with the King Honey asset by an additional $2.36m.

An overview of the activity of the Group for the year is summarized as follows.

Me Today and the Good Brand Company

The strategy in respect to the Me Today brand continues to be the investment into the brand locally

in New Zealand and Internationally.


In New Zealand the brand has a strong national presence in pharmacy and grocery stores with Me

Today stocked in all Countdown stores and partnerships with major pharmacy banners Chemist

Warehouse and Bargain Chemist. Me Today also has a good presence in selected Unichem and Life

Pharmacy stores as well as a number of good independents throughout New Zealand.


2



The international strategy remains focused on the following core markets, US, Japan, Ireland, the

UAE and Australia.


• In Ireland the brand is listed with Chemist Warehouse and Tesco and is also stocked in

selected pharmacy stores around the country.

• In the US the positioning of the brand is in partnership with major Online platforms. The USA

business of Me Today has a logistics hub based out of Arkansas with orders distributed from

this warehouse nationwide in the USA. The brand is also in discussion with bricks and mortar

retailers, and it is fulfilling orders through a west coast broker.

• Repeat orders continue in Japan and the UAE and we continue to develop the brand and

partnerships in these markets.

• In Australia we have an Online presence, and we are in discussions with two large retailers in

respect to a wider listing.


Across all markets Online sales are proving to be a good way of building the brand footprint and

creating interest in the brand to enable access to big box retailers.


Together with the core market strategy the brand continues to invest in new product development.

Launched in the 2023 financial year have been the following new products.


• 3 UMF rated Me Today Manuka Honey products

• 4 Me Today Manuka Honey Lozenges

• 9 new Me Today supplements

• 4 Me Today Manuka Active skincare products



Projects under development for launch in the remainder of the 2023 calendar year include.


• Me Today Super Honey which will see a range of infused honey products launched


From a product development perspective we will continue to see development across the 3 key

product platforms being: Manuka Honey, Supplements and skincare.


The Good Brand Company


The Good Brand Company represents the groups brands being: Me Today and Superlife whilst also

representing 4 other agency brands. The group has invested in people growing the expertise and

skillset of its staff to support the growth of The Good Brand Company’s stable of brands and has

capacity to bring on new agency brands with the right fit.


The King Honey business


King Honey operates a fully integrated Hive to table Manuka honey business. It has production,

storage and a bottling facility in Taupo and operates a beekeeping operation based out of Turangi.

As discussed above the beekeeping operations have been further reduced through the closing of the

Wairarapa unit leaving a 1,600-hive operation managed from Turangi. King Honey has a large

quantity of beekeeping equipment which means that it has the ability to increase hive numbers as

demand requires.


3


King Honey manages the production of the BEE+ and SuperLife brands as well as contract packing on

behalf of a number of other labels.


BEE +

The group continues to have a good relationship with the Bee+ Brand through Access Corporate

Group (ACG) and its brand management division Access Brand Management (ABM). ABM and the

Me Today Group jointly own the Bee+ Mānuka honey brand.


In conjunction with ABM, Me Today has developed new product offerings with the BEE+ brand

which it has produced and delivered during the FY23 year. ABM are committed to the development

of the brand and Me Today are continuing to support ABM in respect to the growth of the brand.


SuperLife


SuperLife provides the Group with a Mānuka honey brand that competes in different parts of the

market to both Me Today and BEE+. It has customer and distributor relationships across a number of

international markets. The opportunities within these markets continue to change as the sell-

through rate of products is established.


The largest opportunity for SuperLife continues to be the relationship with a US grocery chain. Sell

through has been positive for FY23 with sales into the US for SuperLife more than NZD $1m for the

2023 financial year. Range extension and new product development opportunities exist with this

retailer.


Outside NZ and the USA, the focus markets for SuperLife are Germany, Romania and the UAE with

sales and reorders into these markets over the past six months.


The key aspects of the Group’s consolidated financial statements for the year to 30 June 2023 is

explained further below:


• The Operating EBITDA loss for the Group was $5.15m, split between the business divisions

as follows.

o The Me Today sale of goods and agency services segment operating EBITDA loss was

$2.53m.

o The King Honey segment operating EBITDA loss was $1.23m.

o The listed company and shared services operating costs were $1.39m.

Operating EBITDA excludes one-off and non-cash items amounting to $7.82m from the net loss after

tax of $12.97m.

The $7.82m of expenses consisted of the following.

• Loss on Harvested Honey $2.22m

• Finance Costs $0.59m

• Fair Value loss on Biological Assets $0.54m

• Depreciation and Amortisation

not capitalised to biological assets $0.45m

• Amortisation of the customer relationship asset $1.08m

• Impairment of customer relationship asset $2.36m


4


• Restructuring & Acquisition costs $0.45m

• Write Down of Assets held for sale $0.13m


Total Expenses deducted from EBITDA $7.82m

Further explanation of these are provided below.


o Loss on Harvested Honey

As advised earlier in the year the 2023 Harvest was significantly impacted by the adverse

weather events in early 2023. The total yield achieved from the hive placements was 61

tonnes of honey. The yield was down 50% on what is expected from an average season. In

addition, the quality in terms of active manuka factor, of the Manuka honey harvested was

also significantly lower meaning the value of the honey harvested was much less than

anticipated. These factors resulted in a loss on harvest of $2.22m.


o Impairment of the Customer Relationship Asset

The Group completed a valuation of intangibles acquired at acquisition. Customer

relationship assets were separately identified and valued at $9.3m at acquisition

date. The Group has determined 8 years as the appropriate useful life for this asset

resulting in an annual amortisation charge of $1.08m.

In addition, as part of the year end audit process the directors completed a

discounted cashflow valuation of the King Honey cash generating unit. Following the

completion of this assessment a decision has been taken to write down the

intangible asset by a further $2.36m.

o Closure of beekeeping branches and Consolidation of the Taupō Production Facility

The following costs have been incurred as a result of the decision to reduce the size

of the beekeeping operation and the consolidation of the Taupō Production Facility.

• The reduction in hive numbers has resulted in a biological asset fair value

loss of $0.54m.

• Property, plant and equipment and biological assets with a combined

carrying value of $0.57m have been identified as assets held for sale. These

have been assessed at fair value resulting in a write down of $0.13m.

$0.09m remain unsold as 30 June 2023.

• Restructuring costs of $0.337m have been incurred in relation to closing

beekeeping branches and consolidating the Taupō Production Facility.


5


The Group's outlook for the year ahead remains challenging. However, the Group is confident that it

has the right strategies in place to reduce costs and improve sales across its brands. The Group will

continue to review its options for funding and will make further announcements as appropriate.


For further information, please contact:

Grant Baker

Chairman, Me Today Limited

021 729 800


Michael Kerr

Chief Executive Officer, Me Today Limited

021 836 451

michael@metoday.com

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.